Keeping it in the Family
Research and Development spending at 14 privately owned, mid-sized European pharmaceutical firms averages 12% of 2001 total revenue, a contrast from the 17.7% average at their publicly traded counterparts.
You may also be interested in...
Scanwell Health, a leader in smartphone-enabled home diagnostics tests, has announced a partnership with Beckton Dickson.
908 Devices, Zimmer Biomet and Ortho Clinical Diagnostics have all appointed new directors, Biolase promotes executive vice president to chief executive officer role, and more.
The Swedish liquid biopsy start-up expects to be the first company to secure US FDA approval for a metabolism-based urine test for the early detection of kidney cancer in post-surgery patients.